An Omics View of Emery–Dreifuss Muscular Dystrophy
Recent progress in Omics technologies has started to empower personalized healthcare development at a thorough biomolecular level. Omics have subsidized medical breakthroughs that have started to enter clinical proceedings. The use of this scientific know-how has surfaced as a way to provide a more...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Journal of Personalized Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4426/10/2/50 |
id |
doaj-8b35b3cdafeb46b295f5ca96b585af78 |
---|---|
record_format |
Article |
spelling |
doaj-8b35b3cdafeb46b295f5ca96b585af782020-11-25T03:06:16ZengMDPI AGJournal of Personalized Medicine2075-44262020-06-0110505010.3390/jpm10020050An Omics View of Emery–Dreifuss Muscular DystrophyNicolas Vignier0Antoine Muchir1INSERM, Center of Research in Myology, Institute of Myology, Sorbonne University, 75013 Paris, FranceINSERM, Center of Research in Myology, Institute of Myology, Sorbonne University, 75013 Paris, FranceRecent progress in Omics technologies has started to empower personalized healthcare development at a thorough biomolecular level. Omics have subsidized medical breakthroughs that have started to enter clinical proceedings. The use of this scientific know-how has surfaced as a way to provide a more far-reaching view of the biological mechanisms behind diseases. This review will focus on the discoveries made using Omics and the utility of these approaches for Emery–Dreifuss muscular dystrophy.https://www.mdpi.com/2075-4426/10/2/50<i>LMNA</i>Emery–Dreifuss muscular dystrophyOmics |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Nicolas Vignier Antoine Muchir |
spellingShingle |
Nicolas Vignier Antoine Muchir An Omics View of Emery–Dreifuss Muscular Dystrophy Journal of Personalized Medicine <i>LMNA</i> Emery–Dreifuss muscular dystrophy Omics |
author_facet |
Nicolas Vignier Antoine Muchir |
author_sort |
Nicolas Vignier |
title |
An Omics View of Emery–Dreifuss Muscular Dystrophy |
title_short |
An Omics View of Emery–Dreifuss Muscular Dystrophy |
title_full |
An Omics View of Emery–Dreifuss Muscular Dystrophy |
title_fullStr |
An Omics View of Emery–Dreifuss Muscular Dystrophy |
title_full_unstemmed |
An Omics View of Emery–Dreifuss Muscular Dystrophy |
title_sort |
omics view of emery–dreifuss muscular dystrophy |
publisher |
MDPI AG |
series |
Journal of Personalized Medicine |
issn |
2075-4426 |
publishDate |
2020-06-01 |
description |
Recent progress in Omics technologies has started to empower personalized healthcare development at a thorough biomolecular level. Omics have subsidized medical breakthroughs that have started to enter clinical proceedings. The use of this scientific know-how has surfaced as a way to provide a more far-reaching view of the biological mechanisms behind diseases. This review will focus on the discoveries made using Omics and the utility of these approaches for Emery–Dreifuss muscular dystrophy. |
topic |
<i>LMNA</i> Emery–Dreifuss muscular dystrophy Omics |
url |
https://www.mdpi.com/2075-4426/10/2/50 |
work_keys_str_mv |
AT nicolasvignier anomicsviewofemerydreifussmusculardystrophy AT antoinemuchir anomicsviewofemerydreifussmusculardystrophy AT nicolasvignier omicsviewofemerydreifussmusculardystrophy AT antoinemuchir omicsviewofemerydreifussmusculardystrophy |
_version_ |
1724674338245836800 |